Company
Santersus
- Business model
- B2B
Record updated 28 September 2026
About
Revolutionising how to control the human immune and inflammatory response to disease OUR TECHNOLOGY ABOUT US Santersus Santersus is a therapeutic apheresis company developing extracorporeal removal of cell-free DNA from patient plasma. MORE ABOUT US OUR TECHNOLOGY Neutrophil Extracellular Traps (NETs) Neutrophil Extracellular Traps (NETs) are fibers of decondensed DNA decorated with cytotoxic proteins that